Neuraxis inc. to participate in the lytham partners 2025 investor healthcare summit on january 13, 2025

Carmel, ind., jan. 06, 2025 (globe newswire) -- neuraxis, inc. (“neuraxis,” or the “company”) (nyse american: nrxs), a medical technology company commercializing neuromodulation therapies addressing chronic and debilitating conditions in children and adults, today announced that ceo brian carrico will participate in a webcasted company presentation at the lytham partners 2025 investor healthcare summit, taking place virtually on monday, january 13, 2025.
NRXS Ratings Summary
NRXS Quant Ranking